Republican Lawmakers in Ohio Approve Resolution Opposing Cannabis Legalization

Republican lawmakers in Ohio last week approved a resolution opposing the cannabis legalization question that will be put to voters in the state next month and urging citizens to vote ‘no’ on the proposal.  

The resolution contends that “the commercial marijuana industry” paid to write the statute and then “paid to collect the signatures to get the proposed law.” It also ties the state 33,000 overdose deaths between 2011 and 2020 to cannabis by linking them to the debunked “gateway” drug theory and claiming regular cannabis use “more than doubles the risk of developing opioid-use disorder or initiating nonmedical prescription opioid use,” despite evidence that several studies have found cannabis plays a role as an exit drug for some people who quit opioid use. 

“We, the members of the Senate of the State of Ohio, conclude that the proposed statute authored by the commercial marijuana industry does not serve the best interests of the people of Ohio, will bring unacceptable threats and risks to the health of all Ohioans, especially children, will create dangers in the workplace and unacceptable challenges and costs to employers, will make Ohio’s roads more dangerous, will impose significant new, unfunded costs to Ohio’s public social services, and serves only to advance the financial interests of the commercial marijuana industry and its investors.” — SR 216 text   

The resolution says by voting ‘no’ on the reforms, voters would be preserving and protecting the “state’s high quality of life,” health and safety of its citizens, strength and prosperity of its communities, strong economic growth, favorable environment for business success, and “opportunity for all citizens and the future for our young people.”  

The reforms are also opposed by Republican Gov. Mike DeWine and the Ohio Association of Health Commissioners; however, a September poll by Fallon Research found 59% of Ohioans back the proposal with 32% opposed and 9% unsure.  

None of the Senate’s Democratic lawmakers signed onto the resolution.    

End


Tilray Announces Sustainable Packaging Transition For Good Supply Brand In Canada

Tilray Brands, Inc. on Tuesday announced a hemp packaging transition across its Good Supply brand in Canada. The company said it is overhauling the packaging and componentry of flower bags, pre-rolls, and vape tubes and mouthpieces of the Good Supply brand to minimize the amount of single plastic used in production. 

In a press release, Tilray outlined its research with Suzy Insights which found consumers are 50% more likely to purchase a cannabis product that comes in sustainable packaging versus one that doesn’t. 

“Listening to consumers’ feedback and concerns, the mission around sustainability meets the needs of more eco-conscious, and frequent cannabis consumers, sharing active awareness of increased waste production in the industry.” — Tilray in a press release 

The company added that the program would help divert more than 288,800 pounds of plastic from landfills annually, based on Good Supply sales volumes as of June 2023. Tilray has also partnered with PrintReleaf to reforest more than 2000 trees as of August 2023, from label usage, to offset more than 150,000 pounds worth of paper consumption. 

Tilray indicated it plans to roll out its new packaging for its Canadian brands, including RIFF and Broken Coast.  

The effort is part of Tilray’s new “Green You Can Feel Good About” campaign. 

End


Harvard Creating Study of Psychedelics in Society and Culture

Harvard University is creating a Study of Psychedelics in Society and Culture — an interdisciplinary effort across the Faculty of Arts and Sciences, Harvard Law School, and Harvard Divinity School — which aims to “transform the psychedelics research landscape by producing cutting-edge scholarship and convening faculty, students, and experts to engage in discussion around their far-reaching implications.”   

In a statement announcing the program, Robin Kelsey, Shirley Carter Burden Professor of Photography and dean of arts and humanities, said the university “is uniquely poised to become the most exciting place to debate, discuss, and innovate in this area.” 

The effort will be funded with a $16 million gift from the Gracias Family Foundation. Antonio Gracias, president of the foundation and the founder, chief executive officer, and chief investment officer of Valor Equity Partners, said in a statement, that “Harvard is the ideal place to explore the topic of psychedelics from new angles and to craft a framework for their legal, safe, and appropriate impact on society.” 

In a statement, Michael Pollan, professor of the practice in Harvard’s Creative Writing program and Lewis K. Chan Arts Lecturer, described the gift as “visionary… in that it is the first to take the so-called psychedelic renaissance beyond medicine, by recognizing the importance of the humanities in exploring the impact and potential of these remarkable substances.” 

Bruno Carvalho, interim director of the Mahindra Humanities Center, said in a statement that the initiative will give researchers “the space to explore and enrich public dialogue around psychedelics, including their potentials, as well as ethical and social implications.” 

In 2021, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School established its Project on Psychedelics Law and Regulation to examine the ethical, legal, and social implications of psychedelics in research, commerce, and therapeutics. Additionally, the Center for the Study of World Religions at Harvard Divinity School examines psychedelics as they relate to altered states of consciousness, the relationship of mind and matter, and the global history of spirituality and religion. 

End


Minnesota Cannabis Company Gets $10M State Loan to Turn Former Lumber Mill Into Cultivation Site

A Minnesota economic development agency on Tuesday approved a $10 million loan for a Missouri-based cannabis company planning to build an indoor cultivation operation in a former lumber mill in Grand Rapids that has sat vacant for the past 15 years, MPR News reports. The company, HWY35, said the site will create 400 jobs over two phases of construction that will average $24 an hour, with annual salaries ranging from $40,000 to $160,000. 

Financing for the project also calls for a $10 million loan from the Minnesota Department of Employment & Economic Development and $2 million in tax increment financing from Grand Rapids. 

In a statement, Rob Mattei, community development director for the city of Grand Rapids, said the project will “further diversify” the city’s manufacturing base, “fully utilize the public’s past and present investments in infrastructure and substantially contribute to the growth” of the regional economy. 

Ida Rukavina, commissioner of Iron Range Resources and Rehabilitation (IRRR), the development agency that approved the $10 million loan, told MPR that the project helps achieve the agency’s goal of diversifying the regional economy away from mining and timber. 

“We know that not everyone may agree with this type of industry. But it is now legal in the state of Minnesota. This type of manufacturing, if it doesn’t happen here, it is going to happen somewhere else in our state.” — Rukavina to MPR 

Mathew Sjoberg, IRRR director of business development for Iron Range Resources and Rehabilitation (IRRR), added that HWY35 hopes to have licenses secured by the middle of next year and be in operation by the end of next year.  

End


Advocates In Lubbock, Texas Submit Signatures for Cannabis Decriminalization Ordinance

Advocates in Lubbock, Texas on Tuesday submitted their petition to decriminalize possession of small amounts of cannabis in the city after collecting more than twice the number of signatures required to force city lawmakers to vote on the proposal, the Lubbock Avalanche-Journal reports. Freedom Act Lubbock submitted 10,540 signatures to the city secretary’s office, exceeding the 4,800 signature requirement. 

The city secretary’s office still needs to verify the signatures are valid before the issue moves to the City Council. The ordinance aims to decriminalize the possession of less than 4 ounces of cannabis and cannabis-related paraphernalia within the Lubbock city limits and prevent law enforcement officers from using cannabis odor alone as probable cause for a search.  

If the City Council rejects the ordinance, the Freedom Act committee has the option to request a citywide election to determine whether to codify the ordinance. Adam Hernandez, communications chair for Lubbock Compact, told reporters on Tuesday that he expects the council will send the issue to voters.  

“It was not an easy task by any means, and hundreds of hours were spent planning and building out the strategy before we even collected our first signature. This not only shows the popularity of this initiative, but this incredible feat shows what’s possible when Lubbock citizens from every community get involved in the democratic process. But this is only the first part.” — Hernandez via the Avalanche-Journal 

Hernandez added that in six other cities in Texas that have passed similar reforms, the issue has gone to voters rather than adopted by the city councils.  

According to Hernandez, there are about 600 cannabis-related arrests per year in Lubbock. A similar ordinance approved in Killeen in 2022 led to the release of 146 of 188 people who came in contact with police for cannabis possession from November 9, 2022, through February 28, 2023. 

End


Study: Cannabis Consumers See Reduced COVID Mortality & Better Outcomes Than Non-Consumers

Cannabis consumers who contracted COVID-19 had reduced mortality and better outcomes compared to non-consumers, according to a study published this month in the CHEST Journal. The study, using the National Inpatient Sample Database, suggests “the beneficial effect of marijuana use may be attributed to its potential to inhibit viral entry into cells and prevent the release of proinflammatory cytokines, thus mitigating cytokine release syndrome.”  

According to the study, titled “Exploring the Relationship Between Marijuana Smoking and Covid-19 Outcomes,” cannabis consumers that had contacted Covid-19 had significantly lower rates of intubation (6.8% vs 12%), acute respiratory distress syndrome, (2.1% vs 6%), acute respiratory failure (25% vs 52.9%), severe sepsis with multiorgan failure (5.8% vs 12%), lower in-hospital cardiac arrest (1.2% vs 2.7%), and mortality (2.9% vs 13.5%).  

Out of 322,214 patients included in the study, 2,603 were cannabis consumers, which were described as younger and with a higher prevalence of tobacco use; however other comorbidities including obstructive sleep apnea, obesity, hypertension, and diabetes mellitus were more prevalent in individuals who did not consumer cannabis. 

A study published in August came to a similar conclusion, finding active cannabis consumers diagnosed with COVID-19 had better clinical outcomes than non-cannabis consumers, including the decreased need for ICU admission or mechanical ventilation. However, that study included just two hospitals in the Los Angeles, California area and included just 1,831 covid patients. Among those, just 69 reported active cannabis use, representing 4% of the total patients.  

A study published in May demonstrated that the cannabinoids could lower the production of two proteins – angiotensin-converting enzyme II (ACE2) and the serine protease TMPRSS2 – which are commonly hacked by the coronavirus to create a new infection. 

End


Utah Startup Applies to Sell Cannabis DUI Insurance in Oregon

Utah-based startup reepher has applied to sell insurance in Oregon which would cover the cost of defending a cannabis DUI, Axios reports. The cheapest reepher product offered costs $15 monthly and offers $15,000 in potential coverage, including up to $8,000 in attorney fees and $1,500 to recover a towed vehicle.  

The company launched in late 2021 and currently operates in Arkansas, Georgia, Missouri, New Hampshire, and South Carolina, according to the reepher website

CEO Justin Kahn told Axios that, to date, the company has signed up less than 1,000 customers but has raised $1.2 million in investments. 

“There needs to be a new type of coverage that protects people from the financial consequences of their own behaviors, which are not illegal. But if you end up on the wrong side of the risk it can be a costly endeavor.” — Kahn to Axios 

Tom Baker, an insurance law expert at the University of Pennsylvania Law School, told Axios that while it’s “unusual” to offer insurance “for conduct that would be regarded as criminal,” reepher’s products seem similar to “peace of mind insurance” that’s offered for identity theft or for trip cancellation. 

According to Oregon crime statistics, over the past two and a half years, law enforcement in the state made 210 cannabis-related driving under the influence citations and 64 disorderly conduct citations.  

End


Green Thumb Industries Employees In Reno, Nevada Vote to Join Union

Workers at Green Thumb Industries in Reno, Nevada last week voted to join the United Food and Commercial Workers (UFCW) Local 711.  

In a statement, Green Thumb worker Derrick Miles said he and his colleagues “look forward to bargaining a fair contract.” 

“Organizing with your coworkers to hold your company accountable is no easy task. I’m proud to know we stepped up and stood together in solidarity to fight for the security and improved working conditions that a union contract can provide. … I hope more workers in Nevada, especially in cannabis, are emboldened to take action after witnessing successful campaigns like ours and others across the country. The labor movement in our industry and others grows larger every day. Working people around the country are joining together, making it apparent that enough is enough.” — Miles in a press release 

Last year, about 60 cannabis workers at the Green Thumb-owned RISE dispensary in Henderson voted to join the UFCW Local 711. In March, a complaint was filed with the National Labor Relations Board (NLRB) accusing Green Thumb of violations related to labor law concerning unionization, including, coercive rules, discipline, refusal to bargain or bargaining in bad faith, and repudiation or modification of contract. A prior complaint filed with NLRB accused Green Thumb of discharging employees and other discipline associated with their unionization efforts. 

In August, workers at Las Vegas’ MedMen dispensary voted to join the Local 711.  

End


Healer CBD Expands Its Wellness Offerings with Non-Impairing “Acidics” Gummies

Brunswick, ME – October 6, 2023 – Healer CBD, a leading provider of hemp wellness oils, capsules and topicals nationwide, today announced it launched a new line of full-spectrum functional gummies made from hemp featuring three distinct formulations that contain beneficial acidic cannabinoids not present in most gummies currently available.

Called Ease, Rest, and Vitality, Healer hemp gummies are rare because they contain the acidic cannabinoids CBDA and CBGA, which are known for their powerful pain relief, anti-inflammatory, immune-supporting, and neuroprotective properties. Recent studies show that cannabinoids in their original “unheated” acidic form have tremendous healing properties that act in tandem with and in contrast to their neutral counterparts.

The gummies were developed by Dr. Dustin Sulak, an osteopathic physician recognized globally by his peers as a pioneer of cannabis clinical applications, formulations, and dosage protocols. A leading expert on the therapeutic potential of cannabinoids, he is the author of the first foundational text on the clinical use of cannabinoid therapies, titled Handbook of Cannabis for Clinicians: Principles and Practice. 

Each  functional “acidic” gummy contains unique, consistent ratios of full-spectrum CBDA and CBGA along with their neutral (and better-known) counterparts CBD and CBG, plus other beneficial acidic and neutral minor cannabinoids extracted from specially selected organic hemp strains grown in Maine. Specifically:

To maximize wellness, Healer gummies are non-impairing, vegan, gluten free and made with organic ingredients and all natural, plant-based flavorings and colorings. Each serving contains less than 3 grams of sugar and no corn syrup. These gummies contain 10 mg of cannabinoids and less than 0.3% THC in accordance with federal law.

To ensure consistency and consumer safety, every batch is third-party lab tested. A Certificate of Analysis (COA) verifying the product’s contents and the absence of heavy metals, pesticides, solvents and other biocontaminants is prominently available via QR code on the label. A companion Usage Guide & Response Tracker booklet accompanies each product.

“We devoted a lot of time and effort over the past year to ensure the taste and effects meet the standard of excellence that our customers depend on to improve their overall health and well-being,” said Bradley Feuer, Healer CBD co-founder and CEO. “The initial response through consumer testing has been tremendous in regards to the taste, effects and the quicker onset compared to other edibles.”

It appears these gummies are a game-changer for people who want the health benefits of cannabinoids without impairment, but prefer delicious gummies to conventional oil drops or capsules, he said.

Healer CBD Ease, Rest, and Vitality gummies are available now at HealerCBD.com and a growing number of retail outlets.

###

About Healer CBD

Healer is a trusted, physician-developed hemp brand and educational resource founded to help consumers and healthcare providers get the best results with safe, reliably dosable products and education on how to best use them. Healer’s educational content and distinctive product formulations are based on the latest science, clinical research and 13 years of clinical work by Dr. Dustin Sulak.

Healer CBD’s paradigm-shifting patented nano-filtration extraction process sets a new standard for maintaining the plant’s valuable components while removing harmful contaminants. To learn more visit https://healercbd.com/healer-spectrum/#our-process.

Healer Whole Plant Hemp products are available nationwide. For education on how to use hemp as medicine or information about Healer Hemp products, visit www.HealerCBD.com.

About Dr. Dustin Sulak
Dustin Sulak, DO is a co-founder of Healer CBD and the founder of Integr8 Health, a medical practice in Maine that follows over 8,000 patients using medical cannabis and hemp. His practice balances the principles of osteopathy, mind-body medicine and medical cannabis.

Regarded as an expert on medical cannabis, Dr. Sulak educates medical providers and patients on its clinical use, while continuing to explore the therapeutic potential of this ancient yet emerging medicine.

Globally recognized by his peers as a pioneer of clinical applications, formulations, and usage protocols, Dr. Sulak is the author of the first foundational text on the clinical use of cannabis and cannabinoid therapies, titled Handbook of Cannabis for Clinicians: Principles and Practice [https://wwnorton.com/books/9780393714180].

Dr. Sulak received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an internship at Maine-Dartmouth Family Medicine Residency.

End


Pioneering the Sample Economy in the Cannabis Industry with the Smallest Vape

Artrix, a leader in cannabis vaporization business solutions, specializing in hardware manufacture, marketing support, and strategic consultation, today announces the launch of its ground-breaking new product category, DEMO. This game-changing device is the world’s smallest cannabis vape and represents Artrix’s premier solution to inaugurate the era of ‘sample economics’ in the cannabis vape consumer market.

ArtrixDEMO has been meticulously designed to meet the four most essential consumer needs in purchasing a cannabis vape pen : ease of use, flavor, discreetness, and portability. Beyond that, DEMO aims to tackle customer hesitation in trying new cannabis concentrate products and alleviate the costs of market expansion for cannabis vape companies and multi-states operators.

“DEMO is the smallest cannabis vape on the market, measuring only about 5cm in length and weighing less than 8g. It feels like an AirPods earbud, incredibly lightweight and compact. ” “Many clients are often curious as to why we have set the capacity of the DEMO at 0.1g. In fact, we have conducted extensive research on the consumption habits of the majority of cannabis vaporization consumers. Average cannabis vaporization consumers take around 5-9 draws per day, and the 0.1g capacity allows for approximately 8 draws. This capacity precisely meets the daily consumption needs of average cannabis vaporization consumers. DEMO ensures consumers fully experiencing the ultimate potency and aroma of a cannabis extract.” said Jessy Chen, Chief Product Officer at Artrix.

DEMO has a minuscule size and limited capacity, which is attributed to a cost-effective vape sample for consumer trials and an excellent product solution for promotional purposes. The innovation is tailored to meet urgent needs of cannabis business customer sets including cannabis vape brands, multi-state operators, cannabis processors, and dispensaries.

Amid the steep decline in the survival rate of new products in the current cannabis vaporization market, DEMO offers cannabis entrepreneurs a product solution of sample economics to test the market receptivity of new products and a diversified promotion strategy for the final product success.

“Sample economy has been well-proven in other fast-moving consumer goods sectors, particularly in online-store or in-store sales. Shopping small sample can effectively increase sales volume, customer retention, and also help attract new customers and agents. That’s why we launched this entirely new product category of cannabis vape, DEMO. It has better portability than a disposable, with more possibility than a pod-system. It can help cannabis businesses penetrate new markets, expand new sale channels, and reach more consumers in the form of trial packs, gift sets, and promotional giveaways,” said Jessica Min, Chief Business Officer at Artrix. “DEMO is suitable for cannabis businesses of all sizes to promote their cannabis extracts, whether the target audience is distributors, retailers, or consumers. DEMO offers a new business growth solution for cannabis brands to empower their existing cannabis product lines, and provides final consumers a simpler, portable, and affordable way to experience cannabis products.”

Artrix’s DEMO is now available to customers not only in the United States and Canada, but also internationally, providing:

  • New Product Testing: Market entry often comes with high marketing costs and risks of failure. DEMO can be used as a small sample or trail version to test the market acceptance at a lower cost, and increase its success rate.
  • Product Promotion: DEMO offers diverse promotional strategies to increase sales volume and retention rates, including member gifts, sample giveaways, gift sets, travel size choices, new register gifts, lottery events, etc.
  • Interstate Commerce: For multi-state operators, DEMO allows consumers use big brands at low prices that assist in rapid expanding sales channels, engaging consumers, and lowering the risk of entering new markets.
  • Cross-Industry Business Exploration: DEMO is adapted for low-cost, low-risk cross-industry business explorations. Quickly test the compatibility and performance of different cannabis extracts and vaporization devices to find new areas for profitable growth.

About Artrix – Hardware, Marketing, Strategy, We’re All in.

Artrix is an emerging international cannabis vaporizer hardware brand that offers more than just cannabis vape devices. It uses an exclusive three-in-one service model that combines superior product solutions, systematic marketing support, and professional strategic consulting to create a great customer experience. Artrix conducts extensive market research and analysis to understand the needs behind each product and provides localized marketing support to maximize its market potential and success.

End


Trulieve Contributes Another $500K to Florida Cannabis Legalization Campaign

Multistate cannabis company Trulieve has contributed another $500,000 to Smart & Safe Florida, which is leading the campaign to legalize cannabis for adult use in the state, CBS News reports. In all, the firm has donated $39.55 million to the effort.

Trulieve has contributed all but $124.58 of the funds raised by Smart & Safe Florida, the report says, and the committee had spent $39.545 million as of September 30, according to Florida Divisions of Elections data outlined by CBS News.

In court filings opposing the reforms, lawyers for Florida Attorney General Ashley Moody, who is leading the legal challenge to keep the legalization question off of ballots, claim the proposed constitutional amendment “misleads” voters to benefit Trulieve. In the brief, Solicitor General Henry Whitaker said the ballot summary “misleads in ways that, though sometimes subtle, are likely to influence voters – and to do so in a way that entrenches the sponsor’s monopolistic stranglehold on the marijuana market to the detriment of Floridians.”

The state Supreme Court is set to hear Moody’s challenge to the ballot measure next month.

poll released last month from the University of South Florida and Florida Atlantic University found that 60% of respondents back adult-use cannabis legalization in the state, with 29% opposed and 11% unsure.

End


Two New Jersey Men Plead Guilty to Cannabis Investment-Related Fraud

Two New Jersey men last week pleaded guilty to two counts of fraud related to swindling investors in CanaFarma Corp. and CanaFarma Hemp Products Corp. Vitaly Fargesen, who served as CanaFarma senior vice president of strategic planning, and Igor Palatnik, the company’s senior vice president of product acquisition each pleaded guilty to one count of conspiring to commit securities fraud and one count of conspiring to commit wire fraud in association with the scheme. 

The duo were initially charged last year for misappropriating at least $4 million in investor funds, in what U.S. Attorney Damian Williams described as “a sophisticated scheme to obtain millions of dollars from investors with the promise that their money would be spent on building a legitimate company.”     

“Instead, they lied about their business, lied to their auditors, and stole millions of dollars of investor funds. Today’s guilty pleas reflect my Office’s commitment to prosecuting those who greedily lie to investors to line their own pockets.” — Williams in a press release 

According to prosecutors, Fargesen and Palatnik used their control to raise about $14 million in funds, including investments in private shares of CanaFarma, with false and misleading representations concerning the company’s management, products, and financials and failed to invest investors’ funds as promised and used those funds for personal use. Fargesen and Palatnik effectuated the scheme by controlling CanaFarma through a nominal CEO who reported to the duo and lied to investors regarding CanaFarma’s actual and anticipated operations and attempted to artificially inflate CanaFarma’s reported revenue by making false statements to CanaFarma’s auditors, and misappropriating millions of dollars of investor funds. 

The combined charges carry a maximum sentence of 10 years in prison. Both men are expected to be sentenced in January. 

End


Poll: Majority of New Jersey Residents Smell Cannabis In Public; Most Unbothered By It

In a Stockton University poll, a majority of New Jersey adults – 57% – reported smelling cannabis in public spaces often (28%) or sometimes (29%) with another 32% saying they smell cannabis rarely, and 9% saying they have never smelled cannabis in public. 

A majority of the respondents – 52% – though, said they are not bothered by the smell, while 19% said the odor bothers them a great deal and 28% said it bothers them slightly.    

In a statement, John Froonjian, director of the William J. Hughes Center for Public Policy at Stockton University, which conducted the poll, noted that “Not much thought was given to the issue of the smell of marijuana becoming part of the public landscape in New Jersey.”   

“There are hardly any places to legally consume these products, so people are lighting up in parks, at festivals, in parking lots and on the street.” — Froonijian in a statement 

Last year, New Jersey regulators approved rules for cannabis consumption lounges; however, few have opened. 

About 29% of poll respondents said they have smelled cannabis coming from a a neighboring house or apartment often (14%) or sometimes (15%), with 21% saying they rarely smell it at home and 49% said they never do. Another 31% of those polled said they believe that the right to smoke cannabis in your own home should take precedence over not creating an odor for your neighbors, while 16% said residents not having to smell it from neighbors is most important. 

The majority of respondents (56%) said they did not know anyone who had driven while under the influence of cannabis, while 39% said they had; however, fewer residents (51%) said driving while under the influence of cannabis was extremely dangerous, compared to 90% who said the same for driving under the influence of alcohol. The poll found 73% of respondents said it is either very important (46%) or somewhat important (27%) to them to have a roadside test that can determine a person’s level of impairment from cannabis, with 10% saying it is not very important and 13% saying it is not at all important (13%) to develop such a test. 

End


U.S. Census Bureau Releases Interactive Map Outlining States’ Quarterly Cannabis Tax Revenues

The U.S. Census Bureau has released an interactive map outlining the quarterly revenue states have garnered from cannabis excise taxes and what percent of their revenues the taxes represent. The agency’s data covers the second half of 2021, all of 2022, and the first half of this year. 

The data set for Q2 2023 is incomplete with several states where adult-use businesses are operational not included, such as Washington State, New Jersey, and Maryland. Other states, including Virginia and Minnesota have legalized cannabis for adult-use but sales have yet to commence. The data also includes states that impose excise taxes on medical cannabis sales.  

The available data shows that Q2 2023 cannabis tax revenues in five states represented more than 1% of the states’ total tax revenues, including Alaska (1.32%), Colorado (1.21%), Illinois (2.04%), Michigan (2.16%), and Oregon (3.19%). Among those states, only Alaska and Michigan had increases in cannabis tax revenues from the previous quarter, with 18.35% and 8.53% respectively. Colorado saw a 0.33% decrease, Illinois a 3.72% decrease, and Oregon a 7.95% decrease.  

Cannabis tax revenues for two states, Arizona (0.73%) and Missouri (0.92%), represented between 0.5% and 1% of revenue and both saw increases from Q1 figures at 9.73% and 89.4%, respectively.  

The cannabis tax revenues from the remaining states included in the dataset comprised less than 0.5% of the state’s revenues in Q2; those states include California (0.26%), Connecticut (0.05%), Maine (0.11%), Massachusetts (0.42%), Mississippi (0.02%), Montana (0.25%), Nevada (0.17%), New Mexico (0.06%), New York (0.37%), Oklahoma (0.09%), Pennsylvania (0.20%), Rhode Island (0.13%), Vermont (0.04%), and Washington, D.C. (0.01%).   

End


Maryland Judge Imposes Injunction Against Ban On Intoxicating Hemp Products

A judge in Maryland on Thursday imposed a preliminary injunction against the enforcement of a state law that prohibited the sale of intoxicating hemp products, the Washington Post reports. The lawsuit against the rules was filed in July by the Maryland Hemp Coalition and several hemp farmers and businesses.  

Under the law, only businesses that had medical or adult-use cannabis licenses in the state were permitted to sell intoxicating hemp products and the lawsuit argued that those restrictions violate the Maryland Constitution’s equal protection and anti-monopoly clauses by effectively shutting down their businesses and excluding them from a tightly regulated market. The decision by Circuit Court Judge Brett R. Wilson will allow those businesses to remain operational while the case makes its way through the legal process. 

In a statement, William Tilburg, director of the Maryland Cannabis Administration, said the agency “was disappointed to learn of the preliminary decision in Washington County Circuit Court allowing for the continued sale of unregulated, untested, and intoxicating hemp-derived products.”   

The judge’s order has no effect on the state’s adult-use cannabis licensing process, which is currently underway.  

End


Alabama Medical Cannabis Regulators Pass New Rules; Aiming to Issue Licenses by Year’s End

The Alabama Medical Cannabis Commission (AMCC) on Thursday passed new rules to reset the license application process for the third time, WIAT reports. Under the new rules, the agency will reconsider the applications they already have, and the scores will remain, but the applicants will now have the opportunity to make a public presentation to the commission about why they should receive a license.  

The new rules come amidst lawsuits related to the state’s licensing process so far: one alleging the AMCC failed to follow the state’s open meetings law, and another from Medalla LLC that claims the AMCC defamed the company when its evaluations implied, inaccurately, that one of the company’s owners or senior directors had a criminal record. 

A lawsuit filed against the AMCC by Verano Holdings that claimed the agency had no right to issues, then rescind, its medical cannabis license was dismissed by a Montgomery County Circuit Court judge on Wednesday, according to Alabama Daily News.  

In an interview with the Associated Press, Commission Chairman Rex Vaughn described Thursday’s move as “kind of a reset.” 

“We think we have a process to move forward,” he said, “not ditching what we’ve already done, but making use of it as best as possible.” 

The commission hopes to finally award the licenses by the end of the year.  

End


Study: Hemp Could Be Beneficial Cover Crop for Wine Vineyards

Planting hemp as a cover crop in wine vineyards could be beneficial, according to a study conducted by New Zealand researchers outlined by New Zealand Wine Grower. The research, conducted over three years in Marlborough Sauvignon Blanc vineyards by grape grower Kirsty Harkness and viticulture researcher Dr. Mark Krasnow, found the hemp did not compete with the vines and beneficially affected the soils and wines. 

Additionally, the hemp became established without supplemental irrigation during an exceptionally dry season when other cover crops failed to thrive, allowing the plants to sequester carbon longer into the season. Soils from the hemp area were also higher in organic matter and total carbon, which are beneficial for the long-term health and fertility of the soil. Differences were especially pronounced at about 16-31 inches, suggesting that hemp allows the sequestration of more carbon deeper into the soil profile than other cover crops or resident vegetation. Juice from grapes adjacent to the hemp also had greater populations of native yeasts and produced a wine of higher quality than juice from vines located far from the hemp. 

The differences in native yeast populations brought about by a hemp cover crop is an aspect sparking much interest. The suggestion that hemp could improve wine quality is an interesting further study topic, but not a path I’m currently going down. As a grape grower, my focus is on producing the highest quality fruit, and improving soil health in vineyards.” — Harkness to New Zealand Wine Grower 

Krasnow added that the hemp’s lack of competition with the vines was “a little surprising, considering how large some of the plants grew.” 

“Its ability to survive with little water, its robust root system which adds carbon to the soil, and its ability to grow in and improve compacted soils, makes it a useful tool for vineyard management,” he said. 

End


Survey: Majority of U.S. Truckers Favor Changes to Federal Cannabis Testing Regulations

Nearly two-thirds of U.S. truck drivers and their carriers favor changes in federal cannabis testing regulations, according to a report from the American Transportation Research Institute (ATRI). The report found that 41.4% of truck drivers reside in states with legal adult-use cannabis access in 2023, compared to 18.5% in 2019.  

The ATRI survey found 70% of truck drivers and 62% of representatives from motor carrier companies said that “changes were needed to federal drug policy rules in light of state-level legalization” and another 65% of all respondents agreed that some form of cannabis impairment testing should replace cannabis use testing. 

In a statement, Minnesota Trucking Association President John Hausladen noted that more states are legalizing cannabis which “underscores the critical need for tools to effectively determine marijuana impairment by current and prospective employees.” 

Federal law mandates that commercially licensed drivers submit to both pre-employment and random cannabis urinalysis testing, which detects the presence of THC metabolites but does not test for impairment because the metabolite can remain detectable in urine for weeks. 

According to Drug and Alcohol Management Information System (MIS) data, from 2012 to 2021, 1,057,692 drug tests have been performed on drivers with a 66.9% positive test rate for cannabis. Among those more than one million tests, 572,306 were pre-employment drug screens, which had a 71.1% positivity rate for cannabis. Another 455,901 of the tests were random, which had a 58% positivity rate for cannabis. 

The report notes that “The federal prohibition of marijuana use by [Commercial Driver License] holders has been highlighted as a potential disincentive for drivers to stay in the industry” and that the high pre-employment positivity rates, which likely purport past cannabis use “is filtering out a significant number of potential truck drivers from the industry.” 

End


Cannabis Company Files Lawsuit Against ‘Stacking’ of Adult-Use Sales Taxes

A Missouri cannabis company is suing the state claiming the sales tax stack on adult-use cannabis sales is unconstitutional, KSHB 41 reports. St. Louis County-based Robust Missouri Dispensary 3 argues that the 3% tax passed by voters in Jackson and Cass counties violates state law and that in February the Missouri Department of Revenue issued a statement that clarified “based on constitutional language, a city and a county cannot ‘stack’ the additional up to 3% local tax on recreational marijuana sales.”

That interpretation is based on Article XIV of the Missouri Constitution, which reads: “The governing body of any local government is authorized to impose, by ordinance or order, an additional sales tax in an amount not to exceed three percent on all tangible personal property retail sales of adult use marijuana sold in such political subdivision.” The “local government” language means a county, according to the Revenue Department interpretation outlined in the lawsuit and, therefore, St. Louis County dispensaries located within incorporated areas are only subject to a municipality sales tax.

Later in February, the Revenue Department issued a statement saying the language of Article XIV is “ambiguous” and that it was rescinding the previous guidance. The statement said that there are “two interpretations” of what “any local government” means and that the agency would no longer advise municipalities or counties on whether or not they could stack sales taxes on adult-use cannabis sales.

The lawsuit seeks to settle in court which interpretation of Article XIV is constitutional and whether or not Missouri counties can stack sales taxes on top of municipal sales taxes for cannabis businesses operating in incorporated areas.

End


Wyoming Advocates Renew Push for Medical and Adult-Use Ballot Questions

Advocates in Wyoming are pushing forward with plans to put adult-use and medical cannabis legalization questions on 2024 election ballots, the Star-Tribune reports. The renewed bid by Compassionate Options Wyoming, Wyoming NORML, and the Wyoming Libertarian Party comes after a misunderstanding of guidance from the secretary of state’s office led them to believe that the proposed measures did not qualify, but they did.  

Initially, the organizers believed they had thousands fewer signatures than needed, so they didn’t submit them to the secretary of state’s office before the March deadline; however, they had actually reached the benchmark. According to updated guidance from the secretary of state, the campaign must now recollect the signatures and submit them before the upcoming legislative session, which begins in January. 

The organizers’ spokesperson Apollo Pazell told the Star-Tribune that the process was “really convoluted and confusing” but that the campaign would seek to extend the process beyond the start of the session due to the confusing guidance from the secretary of state’s office.  

Wyoming requires organizers seeking to put issues on ballots to gather the number of signatures equal to 15% of votes cast in the last general election and reach that same threshold in two-thirds of the state’s counties to put the issue to voters. The petition must be signed on paper, in person. 

Once the sponsors get their petition form from the state, they have 18 months to gather the required signatures and must submit their petition with the signatures before the start of the legislative session in the year that they aim to have their initiative on the ballot. The groups gathered roughly 36,000 signatures for both initiatives before their deadline in March, Pazell said. 

When the organizers received their petition in September from the then-Secretary of State Edward Buchanan, it was impossible to know what the signature requirement would be based on 2022 voter turnout because the elections hadn’t occurred yet, the report says. The signature requirement based on 2020 voter turnout was 41,776 signatures, meaning the measures didn’t reach the 15% threshold for two-thirds of Wyoming’s counties; however, the secretary of state’s office now reports that, based on 2022 voter turnout, 29,730 signatures are required to get an initiative on the 2024 ballot. 

End


Massachusetts Cannabis Company Suing Over Host Community Agreement Fees

A Pittsfield, Massachusetts cannabis company is suing the city over its Community Impact Fees, alleging officials have not identified any “impacts” the company has had on the community, JD Supra reports. Under the state’s legalization law, the Community Impact Fees imposed on cannabis businesses must be “reasonably related” to the costs incurred by a municipality as a result of cannabis business operations and municipalities must furnish annually documentary proof of such costs to operators. 

Berkshire Roots is seeking to recoup $440,000 in Community Impact Fees it paid to Pittsfield since 2018; however, the state’s legalization law does not expressly address whether cannabis businesses may recoup past Community Impact Fee payments that were not in accordance with the law.  

According to the complaint, Berkshire Roots has two so-called Host Community Agreements with the city – one for its medical cannabis operations and one for its adult-use operations.  

Amendments to the state’s legalization law expressly authorize licensees to sue host communities for breach of contract if a licensee believes the preceding year’s municipal cost documentation – which a municipality is now required to provide to an operator during the license renewal process – is not “reasonably related” to the actual costs imposed on the municipality. Under those provisions, licensees can sue to “recover damages, attorneys’ fees, and other costs encompassed in the community impact fee that are not reasonably related to the actual costs imposed upon the city or town,” according to the JD Supra review. Berkshire Roots’ lawsuit does not cite the new law as the legal basis for the lawsuit but references the prior statutory regime and a 2020 Guidance Document issued by the Cannabis Control Commission on Host Community Agreements. 

Pittsfield-based Bloom Brothers filed its own lawsuit against Pittsfield last year and is seeking to recoup $110,000 in Host Community Agreements fees, alleging the city has never provided the documentation showing the company’s impact on the city. 

End


Connecticut Cannabis Sales Surpass $25M In September for New Monthly Sales Record 

Combined medical and adult-use cannabis sales in Connecticut surpassed $25 million in September, setting a new monthly sales record in the state, according to Department of Consumer Protection (DCP) data outlined by CT News Junkie. September also saw the lowest average product prices at $38.21 for medical cannabis and $38.37 for adult-use products. 

The price per product was highest in January at $44.61 and has declined nearly every month since. 

In all, adult-use sales totaled $14.3 million while medical cannabis sales neared $11 million. The majority of total sales – 52% – were flower, followed by vape products (30%) and edibles (11%).   

Adult-use customers purchased 376,035 products in the month of September while medical cannabis patients purchased 284,116 products. 

The September figures issued by DCP are considered preliminary and don’t account for sales tax collected at point-of-sale for adult-use products. Medical cannabis products are exempt from taxes. 

In August, combined cannabis sales in the state totaled $25 million, which set the previous record, with $14 million in adult-use sales and $11 million in medical cannabis sales. 

End


The Hidden Harvest: How Glove Choice Can Boost Profits

Ever shop for disposable gloves and think, “What’s the difference? They all look the same.” A natural reaction would be to find the best deal and click that purchase button with authority knowing you saved money.

There’s so much more to it. We talked in our last article, “Glove Essentials: Cannabis Industry Must Knows” about why gloves are essential safety equipment in the cannabis industry. There is also a big financial component to consider. Duh, right? Stick with me. I’ll explain.

Gloves with Profit Protection?

There will always be a bottom line. A budget that must be met. But purchasing disposable gloves includes more factors than simply the price in your cart. Think of it as like buying an energy-efficient freezer. The sticker price may be slightly higher, but over the life of the freezer it’s going to cost you less than a standard freezer. No, gloves won’t lower your electricity bill – wouldn’t that be great – but purchasing better quality gloves can actually reduce the amount you spend on them over time.

Higher-quality gloves can lower costs in a few different ways. Put your calculator down and listen up. Better gloves reduce:

  • Ripping: It’s no shock that if a product is made with higher quality ingredients and manufacturing processes, it is going to be a better caliber product and likely last longer. The same can be said for gloves. Manufacturers can cut corners and save money by using cheap ingredients and fillers, such as chalk. Basically, they have a large bucket of nitrile ‘goo’. Adding cheap fillers like chalk to the bucket makes more ‘goo’. More ‘goo’ = more gloves for less money.You can see the problem here. The manufacturer makes gloves at a reduced cost. Possibly giving you that ‘Yay, I found cheap gloves!’ feeling. But chalk doesn’t stretch, causing these cheaply made gloves to rip and tear at an extremely higher rate than ones made with high-quality ingredients. Not to mention, if a glove rips when you are handling a product all the ‘glove juice’ inside, made of sweat and whatever else was on your hands, can pour out onto the product … and that is pretty darn disgusting.

  • Glove Use: Have you ever had to put on five gloves to get one to work because they keep ripping or the cuff keeps tearing off? How frustrating and time-consuming is that? The manufacturer adding cheap ingredients and fillers, which degrade the integrity of the glove, could be why. Cheaply made gloves dramatically increases the number of gloves your team actually uses. Buying a box of 100 gloves and having your team only wear and use 60-70% of them drastically increases the cost per glove. Not to mention the hit to your team’s efficiency, because when they are constantly changing ripped gloves, they aren’t working.In contrast, a higher-quality glove (in the correct size) won’t rip when you put it on and will have superior durability, which will also enable it to be worn longer during use. Therefore, the box of gloves that, at first glance, may have a slightly higher sticker price may actually work to protect your team and product better, for a longer period of time and less per glove cost.
    Wouldn’t it be nice if you didn’t have to order as many disposable gloves? We think so. This can also support your sustainability efforts, which I’ll mention more about below. Let’s stick to the financial impact for the time being.
  • Glove Waste: Eliminating ripped gloves that your staff is throwing away without even using and reducing the number of gloves used per shift will lower your company’s overall glove use. Consequently, using fewer gloves also reduces the amount of trash your company disposes, lowering waste disposal costs. This also helps the environment; we’ll dive into that later.
  • Contamination & Recall Risk: Disposable gloves protect your cannabis products from cross-contamination. They should anyway! But imagine for a minute that those gloves, used to protect your product, were dirty and, in fact, were a source of contamination. It’s happened. A cannabis producer and processor actually had a recall because the gloves they used had O-Phenylphenol on them. They did everything right, but new gloves right out of the box had a fungicide on them that was flagged during product testing. How does this happen? If a manufacturer uses dirty water sources or cuts corners by inadequately heating their water tanks (required to sanitize the water), everything in the water can get on the gloves during the washing stage. In turn, everything on those gloves can get on your product!
    We’re not the messengers of doom and gloom. In fact, we’re quite a fun bunch. There are solutions. We understand the sheer number of details you think about and decisions you make every day for your cannabis company, and we realize disposable gloves are likely ones that don’t rise to the surface often.
    The cannabis industry is a unique market as it progresses and develops regulations and testing requirements. Historically, the disposable glove industry has operated on blind trust. There are no ingredient labels on the box. Manufacturers are not required to show how they made the gloves. The user has had one option: to buy, use and trust gloves that they know nothing about. This isn’t fair! …Louder for the people in the back! So, we developed our proprietary glove testing program, Delta Zero™, to mitigate the risk of glove contamination.

  • Worker skin issues: Now, on to those who wear the gloves. We know you care about your staff, and we hear, more often than we’d like, how workers have skin issues from the gloves they are wearing. Straight up, a glove made with higher-quality ingredients and manufacturing processes is less likely to irritate the wearer’s skin, also typically reducing the amount of hand sweat.Commonly, cheap ingredients and chemicals added during manufacturing are what is irritating your workers skin. You can read a deep dive into skin issues caused by gloves here. Working with sore irritated hands all day? That’s just miserable and unnecessary! Not to mention, it decreases workers’ efficiency and increases days needed off work for their skin to heal. Workers need taking care of, and so does your bottom line. A high-quality glove can do both.

A Greener Glove?

Here’s the part about supporting your sustainability initiative with disposable gloves. There are an estimated 300 billion disposable gloves used in the US each year across various industries. We are often asked by companies for the best solution to reduce their environmental impact of glove use. A company can increase their environmental impact in a few different ways: reduce, reuse or recycle.

  • Reduce: In addition to a higher quality glove reducing overall glove use and waste it can also be made thinner, without sacrificing durability, reducing the amount of glove waste even further. To break it down to easy math, if you could successfully use a more durable 3mil glove for a process where you had previously used a 6mil, you’d be cutting your environmental impact in half with a simple product switch! No training or new processes necessary. Currently, we recommend this strategy for glove sustainability.
  • Reuse: Using gloves multiple times is not an option due to contamination risks. So, let’s toss that idea in the garbage…where you could be placing fewer gloves.
  • Recycle: Nitrile glove recycling is currently done by Terracycle, but there are additional investments and carbon impacts that should be considered in your sustainability analysis, such as transport and energy used during recycling.

We are constantly looking for ways to do disposable gloves better. In the meantime, we recommend using high-quality nitrile gloves to reduce cost, contamination risk, skin issues and waste.

Is there anything in the glove world you’d like covered in our next blog? Let me know!

End


USDA Says Genetically Modified Hemp Plant Containing 0% THC Can Be Grown In U.S.

The U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) has approved a genetically modified hemp plant engineered by Growing Together Research Inc. that has reduced THC and cannabichromene (CBC) levels. The agency said it reviewed the plant to determine whether it posed an increased plant pest risk compared to other varietals.

In its letter to the USDA, Growing Together notes that the plant contains 0% THC, which would reduce farmers’ risk of growing so-called “hot crops” which “creates an economic and regulatory risk to farmers who want to grow hemp.”

Growing Together noted in a press release last year announcing the cultivar that from 2018-2020 more than 10% of planted hemp acreage was “hot.” 

USDA, through APHIS, regulates the “Movement of Organisms Modified or Produced through Genetic Engineering” under the Plant Protection Act of 2000.

In a letter to Growing Together, APHIS Deputy Administrator Bernadette Juarez said the agency “found this modified hemp is unlikely to pose an increased plant pest risk compared to other cultivated hemp.”  

“As a result,” she wrote, “it is not subject to regulation under [the Plant Protection Act]. From a plant pest risk perspective, this hemp may be safely grown and bred in the United States.”

End